IGFBP7 is a p53-responsive gene specifically silenced in colorectal cancer with CpG island methylator phenotype. - Wikidata - wikimedia - TriplyDB

IGFBP7 is a p53-responsive gene specifically silenced in colorectal cancer with CpG island methylator phenotype.

IGFBP7 is a p53-responsive gene specifically silenced in colorectal cancer with CpG island methylator phenotype.

http://www.wikidata.org/entity/Q39819786

about

A hippocampal insulin-growth factor 2 pathway regulates the extinction of fear memories Serrated colorectal cancer: Molecular classification, prognosis, and response to chemotherapy STAT3 negatively regulates thyroid tumorigenesis Analysis of the DNA methylation level of cancer-related genes in colorectal cancer and the surrounding normal mucosa.The clinical significance of serrated polyps.Methylation-mediated silencing and tumour suppressive function of hsa-miR-124 in cervical cancer.Characterization of DNA hypermethylation in two cases of peritoneal mesothelioma.Novel application of structural equation modeling to correlation structure analysis of CpG island methylation in colorectal cancer Genetic and epigenetic alterations during renal carcinogenesis.DSC3 expression is regulated by p53, and methylation of DSC3 DNA is a prognostic marker in human colorectal cancer.Functional role of cellular senescence in biliary injury Low levels of IGFBP7 expression in high-grade serous ovarian carcinoma is associated with patient outcome.Fusobacterium in colonic flora and molecular features of colorectal carcinoma.Insulin-like growth factor (IGF) signaling in tumorigenesis and the development of cancer drug resistance.Genome-scale analysis of aberrant DNA methylation in colorectal cancer.Downregulation of insulin-like growth factor-binding protein 7 in cisplatin-resistant non-small cell lung cancer Algorithm to identify frequent coupled modules from two-layered network series: application to study transcription and splicing coupling Igf2 pathway dependency of the Trp53 developmental and tumour phenotypes.The molecular pathogenesis of colorectal cancer and its potential application to colorectal cancer screening Insulin-like growth factor-binding protein-7 (IGFBP7): a promising gene therapeutic for hepatocellular carcinoma (HCC).Emerging role of insulin-like growth factor-binding protein 7 in hepatocellular carcinoma.Molecular pathways involved in colorectal cancer: implications for disease behavior and prevention IGFBP7 is associated with poor prognosis in oesophageal adenocarcinoma and is regulated by promoter DNA methylation.Generating new neurons to circumvent your fears: the role of IGF signaling.Clinical application of the CpG island methylator phenotype to prognostic diagnosis in neuroblastomas.DNA methylation biomarkers as diagnostic and prognostic tools in colorectal cancer.Serrated neoplasia-role in colorectal carcinogenesis and clinical implications.Integrin α1β1 expression is controlled by c-MYC in colorectal cancer cells.The CIMP Phenotype in BRAF Mutant Serrated Polyps from a Prospective Colonoscopy Patient Cohort.Sessile Serrated Adenomas: How to Detect, Characterize and Resect.IGFBP-rP1 induces p21 expression through a p53-independent pathway, leading to cellular senescence of MCF-7 breast cancer cells.IGFBP7: an oncosuppressor gene in thyroid carcinogenesis.Inhibition of Cervical Cancer by Promoting IGFBP7 Expression Using Ellagic Acid from Pomegranate Peel.Role for IGFBP7 in senescence induction by BRAF.Integrative analysis of many RNA-seq datasets to study alternative splicing.Comparison of telomere length and insulin-like growth factor-binding protein 7 promoter methylation between breast cancer tissues and adjacent normal tissues in Turkish women.A novel pit pattern identifies the precursor of colorectal cancer derived from sessile serrated adenoma.Differential gene expression profile in bovine blastocysts resulting from hyperglycemia exposure during early cleavage stages.High CpG island methylator phenotype is associated with lymph node metastasis and prognosis in gastric cancer.DNA methylation profiling of well-differentiated thyroid cancer uncovers markers of recurrence free survival.

P2860

Q24631007-B7400B32-F4EF-4C10-9EAF-1E6E9600AC7C Q26751035-2A17356C-5666-4511-ACF8-EACD22CB3EB2 Q28505424-ADE72A59-F4E5-4555-A782-1149A06F7E18 Q33706656-A6136B5F-E937-4A0F-BB93-38A5ED4A8B3E Q33736606-9BBFF902-93F8-412E-907B-078831E53199 Q34049709-FD229BAC-D03B-45FA-BC73-BA190F4C4972 Q34353359-996F4409-B011-4A51-B946-C7FDD1E80B1A Q34358286-9EB51687-AEF7-488D-A6A5-9A572FFD6644 Q34467232-F5697DD8-5E8C-4C94-BBC7-070BA857CD52 Q34727199-B652FE9A-E898-45A2-9B02-B3B6B3B59A8C Q35143731-DA3704AC-07EC-4D1A-A25A-A55590DA1126 Q35237915-BFDA802B-BB9D-485F-A33D-B949FDFB8D28 Q35404536-ECF55404-E7BC-401D-9AC4-B1E70FB562F8 Q35606589-4CD9D39C-710A-4E73-B23A-55D897246280 Q35694387-1FA88AA3-FDEC-45AD-AD1A-925F89C34351 Q35911664-5DA4972D-14E0-4D37-9A29-7964584A1070 Q36033571-B4A3FE65-8310-4459-83F2-59226FD3E26F Q36386448-77C206A0-72CF-45FD-9CA9-A5694D6A3877 Q36656549-68DBC9C9-3A9B-435E-8CF0-D28255915730 Q36740292-92146F18-121F-42F0-A026-CB8F141CA00E Q37031704-C95DCA8E-4C72-4E2A-97B2-BC75FF4B7BAA Q37139174-EC622327-F702-4BB6-BD50-777AB372B254 Q37559084-99015029-39AC-4FC5-8ACC-E5DE298DB519 Q38094638-928C05AE-FFCD-4ACC-8D79-2FB5B0F98AC1 Q38112248-4AC8951C-6138-4DFC-A447-6342E92E89E4 Q38140769-558075DD-7A26-45E9-A78E-67899530C0EE Q38473801-74BCD4E6-C0C2-4449-9BC5-AFA601CD1D2A Q38861417-18B82C57-73F0-42D2-B6E8-9259A7572E8A Q38981916-2790D483-0DE7-4B9F-8110-77A2A298362E Q39298941-52B234B0-6C54-4DC0-87F0-8A24EF33370A Q39385037-0F614BBA-6721-4115-B8E3-C697F4176FCD Q39707922-CEE349C4-42F9-4B92-9D6A-34BB1A595B80 Q42352208-64160AC2-FD5C-4CD3-AB50-596216E55237 Q42425082-E92D8650-E9C7-4564-AACC-5141186374D2 Q42767121-67C1BD32-EB27-42E0-8586-DAC328024116 Q48281213-4F16C970-F172-4DFE-87A3-6A1105116C1A Q50519251-E1F5095D-FFAA-498D-BE72-895D6855E0C5 Q51847835-8527D116-BDFF-4D30-8CB5-D88AFF6077DD Q54342844-7AA42BE8-73E8-4BF9-9596-353B6FD6C214 Q54387117-009B4684-D391-4059-B7C1-65A83D8E6949

P2860

IGFBP7 is a p53-responsive gene specifically silenced in colorectal cancer with CpG island methylator phenotype.

http://www.wikidata.org/entity/Q39819786

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh

2009年學術文章

@zh-hant

name

IGFBP7 is a p53-responsive gen ...... G island methylator phenotype.

@en

IGFBP7 is a p53-responsive gen ...... G island methylator phenotype.

@nl

type

label

IGFBP7 is a p53-responsive gen ...... G island methylator phenotype.

@en

IGFBP7 is a p53-responsive gen ...... G island methylator phenotype.

@nl

prefLabel

IGFBP7 is a p53-responsive gen ...... G island methylator phenotype.

@en

IGFBP7 is a p53-responsive gen ...... G island methylator phenotype.

@nl

P1433

Q39819786-F1374427-8A37-4ED5-B880-71F7D5E1E1B9

P1476

Q39819786-88E36BA4-66C6-4BD7-B01D-5F11DF2D0C5C

P2093

Q39819786-019FA044-1EE3-455B-B8D4-8FD9D9635CC8

Q39819786-02626AC4-38C5-4443-B8DE-99ADFA5338BE

Q39819786-10F70237-EAB2-45DC-AB0F-58176A534314

Q39819786-352B8B21-76C9-44AC-A28B-E2603EA05F23

Q39819786-5AF2731C-6549-4EDC-AD7B-80B713DF8909

Q39819786-63783DBC-46F7-4BEB-A5DD-BAB971205A09

Q39819786-6D69CEA9-31D9-42AD-8E4E-A39CEF67600E

Q39819786-725F7A68-9D3F-4AD2-8DCB-C766C5061F27

Q39819786-784432F5-DA21-43DD-9313-09E4476F2FD1

Q39819786-8E91B7C7-BD7F-4240-BA4B-AC4CE0C9C3B3

P304

Q39819786-81D40776-867E-48D8-8800-8D41948FE817

P31

Q39819786-83AEC840-00D9-4EBB-BC11-CC79D0D5D999

P356

Q39819786-D1E492F5-0F69-490F-B32A-56A900E924F8

P407

Q39819786-54E5AAE4-08CB-479D-826A-7830AA94E6A5

P433

Q39819786-ADED1E59-9406-4283-8893-61457A9CCC29

P478

Q39819786-9993F061-116F-4C8D-BFEB-9D15B518C952

P577

Q39819786-80FC81D9-EE07-4070-B28F-41EAFAA57C03

P5875

Q39819786-540BBE6D-6E90-4477-92CB-898B38C2F2CC

P698

Q39819786-18DA6C7B-7C7B-47D6-95A1-DE351FD21A98

P921

Q39819786-C1137010-8636-4144-A117-1E40962FAFB4

Q39819786-C991B462-46C1-4DE7-8E48-789781BE5EE7

P356

P1433

P1476

IGFBP7 is a p53-responsive gen ...... G island methylator phenotype.

@en

P2093

Eiichiro Yamamoto

http://www.w3.org/2001/XMLSchema#string

Fumio Itoh

http://www.w3.org/2001/XMLSchema#string

Hirofumi Akashi

http://www.w3.org/2001/XMLSchema#string

Hiromu Suzuki

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Yamamoto

http://www.w3.org/2001/XMLSchema#string

Jean-Pierre J Issa

http://www.w3.org/2001/XMLSchema#string

Kohzoh Imai

http://www.w3.org/2001/XMLSchema#string

Lanlan Shen

http://www.w3.org/2001/XMLSchema#string

Masahiro Kai

http://www.w3.org/2001/XMLSchema#string

Masanori Nojima

http://www.w3.org/2001/XMLSchema#string

P304

342-349

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CARCIN/BGP179

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P577

2009-07-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26701379

http://www.w3.org/2001/XMLSchema#string

P698

19638426

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer